Careium Ab · OMXSTO:CARE

Careium Ab — Q2 2026 Earnings Presentation

12 slides from Careium Ab's earnings presentation, Jul 10, 2026

  1. Slide 1: Interim report Second quarter report 2026

    Interim report Interim Second quarter report 2026 First Quarter 2022 April 29, 2022 July 10, 2026 Carl -Johan Zetterberg Boudrie, CEO & President CEO Tove Christiansson and CFO David Granath

  2. Slide 2: Quarterly Highlights

    Quarterly Highlights • Growth in all Regions – net sales increasing 24.3% to SEK 251.3m • Product and Service sales both increased • Strengthening the recurring revenue foundation • Number of connections to our alarm receiving centres + 6% to 343,600 • Margin negatively affected by initial costs whe

  3. Slide 3: Market Highlights – Nordic & United Kingdom

    Market Highlights – Nordic & United Kingdom NORDIC UNITED KINGDOM SEKm SEKm +33.4% 120 45% 100 50% +13.6% 4% 100 80 45% 80 40% 43% 60 60 40% 57% 95.9 99.4 40 40 87.5 35% 71.9 35% 96% 20 20 Services Products Services Products 0 30% 0 30% Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q2 2025 Q3 2025 Q4 2025

  4. Slide 4: Market Highlights – Netherlands and Other Markets

    Market Highlights – Netherlands and Other Markets NETHERLANDS OTHER MARKETS SEKm SEKm +30.4% +31.6% 30 65% 30 65% 25 21% 25 25% 60% 60% 20 20 55% 55% 15 15 27.9 28.1 50% 50% 10 21.2 10 21.5 75% 79% 45% 45% 5 5 Services Products Services Products 0 40% 0 40% Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q2

  5. Slide 5: Sales and Gross Margin Q2 2026

    Sales and Gross Margin Q2 2026 SEKm Net Sales & Gross Margin • Net sales increased 24.3% to SEK 251.3m (202.1) 300 50% +24.3% – Organic growth of 25.6% adjusted for currency effects 250 43.3% 45% – Growth in all markets 200 42.5% • Product sales increased 33.5% to SEK 72.4m 150 40% 251.3 – UK analog

  6. Slide 6: Profitability Q2 2026

    Profitability Q2 2026 EBITDA and EBITDA% SEKm 35 13.7% 15% 13.0% 30 • EBITDA margin at last year’s levels while EBITDA increased 25 to SEK 34.4m (26.4) 10% 20 34.4 • EBIT amounted to SEK 15.1m (10.0), corresponding to an 15 26.4 5% 10 EBIT margin 6.0% (4.9%) 5 • Profit levels improved driven by grow

  7. Slide 7: Cash Flow Q2 2026

    Cash Flow Q2 2026 Free Cash Flow per quarter and rolling twelve months SEKm • Operating cash flow improved to SEK 26.2m (20.2) 40 60 • Cash flow from investing activities amounted to SEK -21.5m ( -19.2), including SEK 9.1m (10.2) in tangible 30 fixed assets 40 20 35 • Free cash flow amounted to SEK

  8. Slide 8: Repayment of Hybrid Loan

    Repayment of Hybrid Loan • In connection with the listing in 2021, Careium obtained a hybrid loan of SEK 50 million from its former owner, Doro AB. Including interest, the loan was SEK 64 million on June 30, 2026 • On July 9, Careium entered into an agreement to fully settle the hybrid loan by repay

  9. Slide 9: Concluding Remarks Q2

    Concluding Remarks Q2 Positive financial effect Negative financial effect Priorities ahead • Net sales (+24%) and gross profit • Margin pressure from onboarding • Ambition to build Careium into a (21%) growth across all markets and entry projects that support modern, unified European health - – Stro

  10. Slide 10: Q&A Next report: October 22, 2026

    Q&A Next report: October 22, 2026

  11. Slide 11: @careium

    @careium

  12. Slide 12: Disclaimer

    Disclaimer This presentation includes forward -looking information and statements including statements concerning the outlook for our businesses. These statements are based on current expectations, estimates and projections about the factors that may affect our future performance, including global e

Careium — Q2 2026 Earnings Presentation on 6ix